Could 2 years of hormone therapy be enough for some breast cancers?
NCT ID NCT07153757
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 33 times
Summary
This study looks at whether women with a common, early-stage breast cancer can safely take hormone-blocking pills for only 2 to 3 years instead of the usual 5 years. About 2,900 participants will be randomly assigned to either the shorter or standard treatment. The goal is to see if the shorter option works just as well at preventing the cancer from coming back, while possibly causing fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
270 Dongan Road, Fudan University Shanghai Cancer Center
Shanghai, 200032, China
Conditions
Explore the condition pages connected to this study.